Clinical Trials Directory

Trials / Completed

CompletedNCT03201133

Clinical Subgroups in Patellofemoral Pain Syndrome

Clinical Subgroups Identification in Patellofemoral Pain Syndrome Patients

Status
Completed
Phase
Study type
Observational
Enrollment
45 (actual)
Sponsor
Federal University of Rio Grande do Sul · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers

Summary

Patellofemoral pain syndrome (PFPS) is a multifactorial pathology characterized by diffuse retropatellar and peripatellar pain in the knee joint, exacerbated by overloading activities on the patellofemoral joint. However, this disease showed high degree of patients not responsive to therapeutic strategies. This condition occurred because several factors is related to disease such as: (1) proximal factors (involving trunk and hip), (2) local factors (surrounding and or within the patellofemoral joint) and (3) distal factors (involving ankle and foot). Thus, the identification of clinical subgroups based in anatomic changes (proximal, local and distal factors) is a recent strategy that could help in the therapeutic strategies focused on the etiology of the disease, improve responsiveness to treatment, clinical and functional benefits.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNeuromuscular evaluation(1) Muscle trunk endurance test; (2) Hip isometric strength (abductor, lateral rotation, extension); (3) Knee extensor isometric strength; (4) unilateral squat; (5) navicular drop test; (6) muscle architecture at rest of gluteus medius, gluteus maximus,vastus lateralis, vastus medialis and rectus femoris; (7) muscle activation during unilateral squat (gluteus and quadriceps muscles); (8) pennation angle of obliques vastus medialis; (9) medial patellofemoral ligament length; (10) knee pain.

Timeline

Start date
2017-09-01
Primary completion
2017-10-25
Completion
2018-12-01
First posted
2017-06-28
Last updated
2019-04-18

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT03201133. Inclusion in this directory is not an endorsement.